Go Pro

Atea Pharmaceuticals (AVIR) Earnings Date, Estimates & Call Transcripts

Atea Pharmaceuticals logo
$5.19 +0.12 (+2.37%)
As of 10:42 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Atea Pharmaceuticals Earnings Summary

Atea Pharmaceuticals released Q2 2026 earnings on August 12, 2026, reporting an EPS of -$0.41, which topped the consensus estimate of -$0.56 by $0.15. With a trailing EPS of -$2.11, Atea Pharmaceuticals' earnings are expected to grow next year, from ($1.93) to ($1.38) per share.

Latest Q2
Earnings Date
Aug. 12Estimated
Consensus EPS
(Aug. 12)
-$0.56
Actual EPS
(Aug. 12)
-$0.41 Beat By $0.15

Q2 2026 Earnings Resources

Get Atea Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Atea Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

AVIR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Atea Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.53-$0.53-$0.53
Q2 20261-$0.52-$0.52-$0.52
Q3 20261-$0.46-$0.46-$0.46
Q4 20261-$0.40-$0.40-$0.40

Atea Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026-$0.5550-$0.41+$0.1450-$0.41$33.03M-
5/12/2026Q1 2026-$0.60-$0.57+$0.03-$0.57$22.42M-
3/5/2026Q4 2025-$0.49-$0.57 -$0.08-$0.57--
11/12/2025Q3 2025-$0.46-$0.53 -$0.07-$0.53--
8/7/2025Q2 2025-$0.46-$0.44+$0.02-$0.44--
5/12/2025Q1 2025-$0.56-$0.40+$0.16-$0.40--
3/6/2025Q4 2024-$0.35-$0.40 -$0.05-$0.40--
11/7/2024Q3 2024-$0.50-$0.37+$0.13-$0.37--

Atea Pharmaceuticals Earnings - Frequently Asked Questions

Atea Pharmaceuticals (NASDAQ:AVIR) last announced its quarterly earning data on Wednesday, August 12, 2026. Learn more on AVIR's earnings history.

In the previous quarter, Atea Pharmaceuticals (NASDAQ:AVIR) reported ($0.41) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.56) by $0.15. Learn more on analysts' earnings estimate vs. AVIR's actual earnings.

The conference call for Atea Pharmaceuticals' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Atea Pharmaceuticals' latest earnings report can be read online.
Read Transcript

Atea Pharmaceuticals (NASDAQ:AVIR) has a recorded net income of -$158.35 million. AVIR has generated -$2.11 earnings per share over the last four quarters.

Atea Pharmaceuticals' earnings are expected to grow from ($1.93) per share to ($1.38) per share in the next year.


Earnings data for NASDAQ:AVIR is sourced from Fiscal.ai, with the most recent quarter reported on 8/12/2026. New results are added as companies report their earnings.
From Our Partners